Doctors Who Treat Traumatic Stress in Children | NYU Langone Health
View a list of doctors who treat Traumatic Stress in Children at Hassenfeld Children’s Hospital at NYU Langone.
Doctors Who Treat Ulcerative Colitis in Children | NYU Langone Health
View a list of doctors who treat Ulcerative Colitis in Children at Hassenfeld Children’s Hospital at NYU Langone.
Doctors Who Treat Undescended Testicles in Children | NYU Langone Health
View a list of doctors who treat Undescended Testicles in Children at Hassenfeld Children’s Hospital at NYU Langone.
Doctors Who Treat Urinary Tract Infections in Children | NYU Langone Health
View a list of doctors who treat Urinary Tract Infections in Children at Hassenfeld Children’s Hospital at NYU Langone.
Doctors Who Treat Vaginal Cancer | NYU Langone Health
Doctors at NYU Langone’s Perlmutter Cancer Center specialize in treating Vaginal Cancer. Find a doctor.
Doctors Who Treat von Willebrand Disease in Children | NYU Langone Health
View a list of doctors who treat von Willebrand Disease in Children at Hassenfeld Children’s Hospital at NYU Langone.
Doctors Who Treat Wilms Tumor in Children | NYU Langone Health
View a list of doctors who treat Wilms Tumor in Children at Hassenfeld Children’s Hospital at NYU Langone.
Donating Your Eggs | NYU Langone Health
The NYU Langone Fertility Center is seeking women 21 to 32 years old of all ethnicities to donate their eggs to help others achieve pregnancy.
DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLOZASIRAN IN ADULTS WITH HYPERTRIGLYCERIDEMIA (MUIR-3 STUDY)
The purpose of this research study is to look at how safe and effective ARO-APOC3 is at lowering triglycerides in people with hypertriglyceridemia. Hypertriglyceridemia is a condition where there is too much of a certain kind of fat (called triglycerides) in the blood.
Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Severe Hypertriglyceridemia (SHASTA-3 Study)
The purpose of this research study is to look at how safe and effective ARO-APOC3 is at lowering triglycerides in people with severe hypertriglyceridemia. Hypertriglyceridemia is a condition where there is too much of a certain kind of fat (called triglycerides) in the blood. In this study, one group of participants receives ARO-APOC3, while a second group receives placebo, which looks the same but contains no actual ARO-APOC3. You will have a 2-in-3 (66%) chance of receiving ARO-APOC3 and a 1-in-3 (33%) chance of receiving placebo.